ESTUDIO COMPARATIVO DE EFICACIA Y SEGURIDAD DE FOSFOSODA R FRENTE A SOLUCIÓN EVACUANTE BOHM R COMO TRATAMIENTO EVACUANTE PREVIO A CIRUGÍA DIGESTIVA O EXPLORACIÓN COLÓNICA

Status

Not yet recruiting

Phases

Unknown

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2005-000267-26-ES

Enrollment

100

Registered

2005-09-08

Start date

2006-01-12

Completion date

Unknown

Last updated

2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

phase IV,observational, randomized, controled, blind, single center

Interventions

Trade Name: FOSFOSODA Pharmaceutical Form: Oral solution INN or Proposed INN: fosfato monosódico monohidratado, fosfato bisódico dodecahidratado CAS Number: A06AD Current Sponsor code: 3010-E Other de

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Both sex over 18 patients non fosfosoda and Bohm contraindication Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Main Objective: To determine the efficacy and safety of fosfosoda as evacuant previous colonic surgery;Secondary Objective: Investigator acceptability Adverse Drug Reactions frequency;Primary end point(s):	—

Countries

Spain

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026